Yu Wang
Chief Scientist @ EFung Capital
Yu Wang is a startup investor at EFung Capital. · Doctor of Medicine at Beijing Medical University and Ph.D., at Japan Autonomous Medical University.· Director of Chinese Disease Control and Prevention Center from 2004 to 2017.· Distinguished Professor of Tsinghua University;Vice President of the Chinese Preventive Medicine Association, and Executive Director of the Chinese MedicalAssociation. Director of the Institute of Liver Diseases of Beijing Medical University; Vice President of Beijing Medical University; · Deputy Director of the Department of Medicine at Peking University, and Deputy Director of Ministry of Science and Technology of China Biotechnology Development Center.· Won the first prize of National Science and Technology Progress Award, the first prize of Science and Technology Progress of the Ministry of Health, the National Science and Technology Progress Special Award, and the National Outstanding Youth Science Fund.
Last updated:
For AI agents: llms.txt
About EFung Capital
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
EFung Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jinqiao Zhu
Founder
|
|||
|
Luo Fayong
Managing Director
|
|||
|
Pai Zhu
Managing Partner
|
|||
|
Yu Wang
Chief Scientist
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
